Meyer Colin John

CIK 00016623921 companyIRVING, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001662392

Recent Transactions

50 trades

Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−90,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−87,700→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−30,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class B common stock
2023-09-26−74,304→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−17,750→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−35,500→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−17,750→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−25,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−81,633→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−24,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−70,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−95,475→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-08-16$168.74/sh−596→ 81,633 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-08-15$169.07/sh−2,144→ 82,229 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-06+6,000→ 84,373 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-16$80.94/sh−625→ 78,373 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-15$84.76/sh−4,469→ 80,137 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-15$85.77/sh−1,139→ 78,998 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07$84.57/sh−621→ 84,606 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-03$87.35/sh−5,286→ 85,227 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-03-02−88,636→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02+88,636→ 179,149 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$85.23/sh−22,752→ 156,397 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$86.49/sh−34,794→ 121,603 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$87.55/sh−19,099→ 102,504 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$88.50/sh−11,181→ 91,323 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$90.58/sh−810→ 90,513 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-03-02$11.00/sh+88,636→ 162,940 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-03-02−88,636→ 74,304 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-02-28+15,000→ 90,513 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right-to-buy)
2023-02-28+30,000→ 30,000 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right-to-buy)
2023-01-03+95,475→ 95,475 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-01-03+23,513→ 75,513 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-01-03+35,000→ 52,000 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2022-01-03+70,000→ 70,000 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2021-06-16−19,525→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common Stock
2021-06-16$11.62/sh+19,525→ 74,304 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-15$142.08/sh−12,518→ 30,067 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-15$139.98/sh−4,107→ 49,079 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-15$141.09/sh−6,494→ 42,585 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-15$145.11/sh−1,217→ 17,500 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-15$143.98/sh−2,483→ 18,717 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-15$139.14/sh−3,814→ 53,186 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-15$145.92/sh−500→ 17,000 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-15$142.83/sh−8,867→ 21,200 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-14$143.54/sh−12,615→ 64,385 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-14$144.44/sh−4,225→ 60,160 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-14+5,000→ 77,000 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-14$145.49/sh−2,760→ 57,400 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2021-06-14$146.15/sh−400→ 57,000 total

Companies

REATA PHARMACEUTICALS INC
See Remarks

Recent Filings

Address

2801 GATEWAY DRIVE, SUITE 150

IRVING, TX, 75063

View on SEC.gov